1 completed, 1 withdrawn. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Withdrawn 1 |
| Phase 3 | 1 | Withdrawn 1 |
Follow Immune Reconstitution Syndrome: new trials by email Literature Review of Immune Reconstitution Syndrome trials Research Report on Immune Reconstitution Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Impact of Valganciclovir on Severe IRIS-Kaposi Sarcoma Mortality: an Open-label, Parallel, Randomized Controlled-trial. Valganciclovir, Antiretroviral Combinations - Kaposi Sarcoma, Human Immunodeficiency Virus | Phase 2 | Completed | National Institute of Cancerología | 40 | 2015-10-01 | 2022-01-27 |
| Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome (TB-IRIS) Treatment Trial Dexamethasone, Atorvastatin, Naproxen - Immune Reconstitution Inflammatory Syndrome, Immune Reconstitution Syndrome | Phase 2 / Phase 3 | Withdrawn | University of Minnesota | 2014-01-01 | 2013-11-25 |
Acquired Immunodeficiency Syndrome (2) · Immune Reconstitution Inflammatory Syndrome (2) · Sarcoma, Kaposi (1) · Tuberculosis (1)
Blood-Borne Infections (2) · Communicable Diseases (2) · Genital Diseases (2) · HIV Infections (2) · Immune System Diseases (2) · Immunologic Deficiency Syndromes (2) · Infections (2) · Lentivirus Infections (2) · RNA Virus Infections (2) · Retroviridae Infections (2) · Sexually Transmitted Diseases (2) · Sexually Transmitted Diseases, Viral (2) · Slow Virus Diseases (2) · Urogenital Diseases (2) · Virus Diseases (2)
Atorvastatin (1) · Calcium Dobesilate (1) · Dexamethasone (1) · Naproxen (1) · Valganciclovir (1)
National Institute of Cancerología (1) · University of Minnesota (1)
Mexico (1) · Thailand (1)
David R Boulware, MD, MPH (1) · Sasisopin Kiertiburanakul, MD, MHS (1) · Ubonvan Jongwutiwes, MD (1)